Clinical trial
Open Label, Zonegran (Zonisamide) In Partial Onset Seizures
NCT00215592 · Eisai Limited, Industry · Completed
Key facts
| NCT number | NCT00215592 |
|---|---|
| Title | Open Label, Zonegran (Zonisamide) In Partial Onset Seizures |
| Official title | An Open Label Study Of Zonegran (Zonisamide) In Patients With Partial Onset Seizures |
| Lead sponsor | Eisai Limited, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Epilepsy |
| Intervention type | Drug |
| Interventions | Zonegran |
| Enrollment | 1,000 |
| Start date | Oct 1, 2005 |
| Primary completion | Jul 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Jan 8, 2016 |
| Countries | Austria, Denmark, France, Germany, Italy, Norway, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: